Expand ABIO Menu

ABIO Stock Summary and Trading Ideas (Arca Biopharma | NASDAQ:ABIO)

Charts for Today's Stock Price and Implied Volatility in Arca Biopharma


Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for ABIO by Theoretical Edge and Win Rates


Trading Statistics

Key Ratios

Arca Biopharma (ABIO) Frequently Asked Questions

What does Arca Biopharma do?

ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro for the treatment of atrial fibrillation, or AF, in patients with chronic heart failure, or HF. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy.

What symbol and exchange does Arca Biopharma stock trade?

Arca Biopharma trades on the NASDAQ stock market under the symbol ABIO.

What is Arca Biopharma stock price doing today?

As of February 23, 2024, ABIO stock price was flat at $1.63 with 4,573 million shares trading.

What is Arca Biopharma's Beta?

ABIO has a beta of 0.08, meaning it tends to be less sensitive to market movements. ABIO has a correlation of 0.00 to the broad based SPY ETF.

How much is Arca Biopharma worth?

ABIO has a market cap of $23.64 million. This is considered a Sub-Micro Cap stock.

What is the highest and lowest price Arca Biopharma traded in the last 3 year period?

In the last 3 years, ABIO stock traded as high as $4.87 and as low as $1.56.

What are the top ETFs holding Arca Biopharma?

The top ETF exchange traded funds that ABIO belongs to (by Net Assets): VTI, VXF, DFAT, DCOR, DFSU.

Is Arca Biopharma (ABIO) a good investment?

ABIO has underperformed the market in the last year with a price return of -22.4% while the SPY ETF gained +28.4%. ABIO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -12.8% and -1.8%, respectively, while the SPY returned +12.0% and +1.3%, respectively.

What is the support and resistance for Arca Biopharma (ABIO) stock price?

ABIO support price is $1.59 and resistance is $1.67 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ABIO stock will trade within this expected range on the day.